OKYO OKYO Pharma Limited
$1.40▼ -1.41%
Healthcare
Other
After hours
$1.40▲ +0.00%
Sep 11, 7:30 PM ET
Volume 53.7K
Avg Volume (10D) 91.4K
Key Metrics & Fundamentals
Market Cap
$73.47M
P/E Ratio
–
Div Yield
–%
52W Range
1.34 - 3.20
% vs 50 MA
-9.74%
% vs 200 MA
-19.49%
RSI-14
39.0
MACD Histogram
-0.0200
Beta (1Y vs SPY)
1.59
Gross Rev
–
Gross Profit
–
EBITDA
–
COGS
–
Operating Exp
–
Operating Income
–
EBIT
–
Pretax Income
–
Net Income
–
Price & Volume History
Loading chart…
Recent News

OKYO Pharma to Present at Ophthalmology Futures European Forum and iNovation Day at ESCRS 2026
GlobeNewswire · Sep 9, 2026 11:00 AM

OKYO Pharma to Participate in a Fireside Chat at the Cantor Global Healthcare Conference
GlobeNewswire · Sep 8, 2026 11:00 AM
OKYO Pharma Announces Purchase of Shares by Chief Scientific Officer
GlobeNewswire · Jul 28, 2026 11:00 AM
OKYO Pharma to Participate in the BTIG Biotechnology Conference 2026
GlobeNewswire · Jul 27, 2026 11:00 AM
OKYO Pharma Announces Purchase of Shares by Director
GlobeNewswire · Jul 23, 2026 4:00 PM
OKYO Pharma Announces Purchase of Shares by Chief Executive Officer
GlobeNewswire · Jul 23, 2026 11:00 AM
OKYO Pharma Announces Purchase of Shares by Chairman
GlobeNewswire · Jul 22, 2026 4:00 PM
OKYO Pharma Announces Purchase of Shares by Chief Development Officer and Director
GlobeNewswire · Jul 22, 2026 2:00 PM
OKYO Pharma Announces Purchase of Shares by Chief Medical Officer
GlobeNewswire · Jul 22, 2026 11:00 AM
Sector Update: Healthcare Stocks Rise Late Afternoon
MT Newswires · Jul 21, 2026 7:40 PM
Financial Overview - Income Statement
Quarterly
No financial data available. Click Refresh on the ticker to load latest fundamentals.
Social Sentiment
No Reddit posts found for OKYO.
AI Analysis
Click Generate Analysis for an AI-powered summary, bull & bear case, and recent performance review.
Not financial advice.
All data, scores, charts, and analysis on this site are provided for informational and educational
purposes only and do not constitute financial, investment, legal, or tax advice.
Past performance is not indicative of future results.
See our Legal Notice for full details.